Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Scienture Holdings Q3 2026 Results: Net Loss of $6.01M, Loss Widens

Scienture Holdings, Inc. reported a net loss of $12.2 million for the nine months ended September 30, 2026, compared to a $13.4 million loss in the prior year. While revenues increased significantly to $1.65 million, the company remains focused on R&D and specialty pharmaceutical development following its acquisition of Scienture, LLC and the disposition of legacy subsidiaries.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue1.30.6
Gross profit1.00.6
Net income-6.0-3.6
EPS (diluted, $ a share)$-3.76$-4.76

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Revenue, year on year+112.6%
Gross margin81.3%
Operating margin-456.2%
Source

10-Q filed with the SEC, NASDAQ: SCNX. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Scienture Holdings, Inc.: key numbers

Share price
$2.99Close, Nov 16
Market cap
$5.35M
Shares outstanding
1.79MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Scienture Holdings, Inc.

All →
4:06 PM ET 8-K
Shareholder Meeting

Scienture Holdings Shareholder Meeting

Scienture Holdings held its 2026 Annual Meeting of Stockholders on October 28, 2026, where shareholders voted on four key proposals. Stockholders elected five directors to the board, ratified CM3 Advisory as the independent auditor for fiscal year 2026, and approved executive compensation on a non-binding advisory basis.

4:06 PM ET 8-K
Business Update

Scienture Holdings Business Update

Scienture Holdings announced preliminary Q3 2026 revenue of approximately $1.22 million, a 256% sequential increase driven by the launch of REZENOPY and growth in Arbli sales. The company also reported regaining compliance with Nasdaq's minimum bid price requirement after its stock closed above $1.00 for ten consecutive trading days.

5:30 PM ET 8-K
Reverse Stock Split

Scienture Holdings Reverse Stock Split

Scienture Holdings, Inc. implemented a 1-for-25 reverse stock split of its common stock effective October 5, 2026. The action is intended to increase the per-share price to regain compliance with Nasdaq's $1.00 minimum bid price requirement. The split reduces the outstanding share count from approximately 41.1 million to approximately 1.6 million shares.

4:06 PM ET 8-K
Investor Presentation

Scienture Holdings Investor Presentation

Scienture Holdings, Inc. has posted a revised investor presentation to its corporate website and filed it as an exhibit to this 8-K. The company intends to use the presentation in upcoming meetings with analysts and potential investors to discuss its projects, financial performance, and growth opportunities.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.